Related references
Note: Only part of the references are listed.Apoptosis-inducing anti-HER2 agents operate through oligomerization-induced receptor immobilization
Jakob C. Stuber et al.
COMMUNICATIONS BIOLOGY (2021)
Inhibition of the MET Kinase Activity and Cell Growth in MET-Addicted Cancer Cells by Bi-Paratopic Linking
Fabio Andres et al.
JOURNAL OF MOLECULAR BIOLOGY (2019)
High-Throughput Quantification of Surface Protein Internalization and Degradation
Jakob C. Stuber et al.
ACS CHEMICAL BIOLOGY (2019)
EGR1 interacts with DNMT3L to inhibit the transcription of miR-195 and plays an anti-apoptotic role in the development of gastric cancer
Yang Yang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Influence of size and charge of unstructured polypeptides on pharmacokinetics and biodistribution of targeted fusion proteins
Fabian Brandl et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Antibodies to watch in 2019
Helene Kaplon et al.
MABS (2019)
Systemic analysis of tyrosine kinase signaling reveals a common adaptive response program in a HER2-positive breast cancer
Martin Schwill et al.
SCIENCE SIGNALING (2019)
High Frequency of ERBB2 Activating Mutations in Invasive Lobular Breast Carcinoma with Pleomorphic Features
Juan Manuel Rosa-Rosa et al.
CANCERS (2019)
Next generation antibody drugs: pursuit of the 'high-hanging fruit'
Paul J. Carter et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Unbiased Combinatorial Screening Identifies a Bispecific IgG1 that Potently Inhibits HER3 Signaling via HER2-Guided Ligand Blockade
Cecile A. W. Geuijen et al.
CANCER CELL (2018)
Structural insights into the mechanism of action of a biparatopic anti-HER2 antibody
Vaheh Oganesyan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Single-molecule imaging reveals dynamic biphasic partition of RNA-binding proteins in stress granules
Benedikt Niewidok et al.
JOURNAL OF CELL BIOLOGY (2018)
A human endothelial cell-based recycling assay for screening of FcRn targeted molecules
Algirdas Grevys et al.
NATURE COMMUNICATIONS (2018)
Prediction of key genes and pathways involved in trastuzumab-resistant gastric cancer
Chaoran Yu et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2018)
Generation and characterization of ABBV642, a dual variable domain immunoglobulin molecule (DVD-Ig) that potently neutralizes VEGF and PDGF-BB and is designed for the treatment of exudative age-related macular degeneration
Kun Ding et al.
MABS (2017)
Efficient production of bispecific IgG of different isotypes and species of origin in single mammalian cells
Michael Dillon et al.
MABS (2017)
COSMIC: somatic cancer genetics at high-resolution
Simon A. Forbes et al.
NUCLEIC ACIDS RESEARCH (2017)
The making of bispecific antibodies
Ulrich Brinkmann et al.
MABS (2017)
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer
Gunter von Minckwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Rigidity of the extracellular part of HER2: Evidence from engineering subdomain interfaces and shared-helix DARPin-DARPin fusions
Christian Jost et al.
PROTEIN SCIENCE (2017)
HER2 Reactivation through Acquisition of the HER2 L755S Mutation as a Mechanism of Acquired Resistance to HER2-targeted Therapy in HER2+ Breast Cancer
Xiaowei Xu et al.
CLINICAL CANCER RESEARCH (2017)
Activating ERBB2/HER2 mutations indicate susceptibility to pan-HER inhibitors in Lynch and Lynch-like colorectal cancer
Michael Kloth et al.
GUT (2016)
Expression Atlas update-an integrated database of gene and protein expression in humans, animals and plants
Robert Petryszak et al.
NUCLEIC ACIDS RESEARCH (2016)
ABiparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy
John Y. Li et al.
CANCER CELL (2016)
A Potent HER3 Monoclonal Antibody That Blocks Both Ligand-Dependent and -Independent Activities: Differential Impacts of PTEN Status on Tumor Response
Zhan Xiao et al.
MOLECULAR CANCER THERAPEUTICS (2016)
The Perseus computational platform for comprehensive analysis of (prote)omics data
Stefka Tyanova et al.
NATURE METHODS (2016)
Intermolecular biparatopic trapping of ErbB2 prevents compensatory activation of PI3K/AKT via RAS-p110 crosstalk
Rastislav Tamaskovic et al.
NATURE COMMUNICATIONS (2016)
An anti-ErbB2 fully human antibody circumvents trastuzumab resistance
Qiong Lu et al.
ONCOTARGET (2016)
Designed Ankyrin Repeat Proteins (DARPins): Binding Proteins for Research, Diagnostics, and Therapy
Andreas Plueckthun
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 55 (2015)
Pan-HER, an Antibody Mixture Simultaneously Targeting EGFR, HER2, and HER3, Effectively Overcomes Tumor Heterogeneity and Plasticity
Helle J. Jacobsen et al.
CLINICAL CANCER RESEARCH (2015)
Targeting Three Distinct HER2 Domains with a Recombinant Antibody Mixture Overcomes Trastuzumab Resistance
Mikkel W. Pedersen et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Effective Optimization of Antibody Affinity by Phage Display Integrated with High-Throughput DNA Synthesis and Sequencing Technologies
Dongmei Hu et al.
PLOS ONE (2015)
Molecular architecture of the ErbB2 extracellular domain homodimer
Shi Hu et al.
ONCOTARGET (2015)
Identification of Anti-ErbB2 Dual Variable Domain Immunoglobulin (DVD-Ig™) Proteins with Unique Activities
Jinming Gu et al.
PLOS ONE (2014)
voom: precision weights unlock linear model analysis tools for RNA-seq read counts
Charity W. Law et al.
GENOME BIOLOGY (2014)
An Antibody That Locks HER3 in the Inactive Conformation Inhibits Tumor Growth Driven by HER2 or Neuregulin
Andrew P. Garner et al.
CANCER RESEARCH (2013)
Three-dimensional cell culture: the missing link in drug discovery
Susan Breslin et al.
DRUG DISCOVERY TODAY (2013)
Structural Basis for Eliciting a Cytotoxic Effect in HER2-Overexpressing Cancer Cells via Binding to the Extracellular Domain of HER2
Christian Jost et al.
STRUCTURE (2013)
Protein analysis by time-resolved measurements with an electro-switchable DNA chip
Andreas Langer et al.
NATURE COMMUNICATIONS (2013)
Fiji: an open-source platform for biological-image analysis
Johannes Schindelin et al.
NATURE METHODS (2012)
Camera: a competitive gene set test accounting for inter-gene correlation
Di Wu et al.
NUCLEIC ACIDS RESEARCH (2012)
Resistance to HER2-directed antibodies and tyrosine kinase inhibitors
Joan T. Garrett et al.
CANCER BIOLOGY & THERAPY (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Transcriptional and posttranslational up-regulation of HER3 (ErbB3) compensates for inhibition of the HER2 tyrosine kinase
Joan T. Garrett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
Mark D. Robinson et al.
BIOINFORMATICS (2010)
Cell Signaling by Receptor Tyrosine Kinases
Mark A. Lemmon et al.
CELL (2010)
Combination antibody treatment down-regulates epidermal growth factor receptor by inhibiting endosomal recycling
Jamie B. Spangler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Augmented inhibition of angiogenesis by combination of HER2 antibody chA21 and trastuzumab in human ovarian carcinoma xenograft
Anli Zhang et al.
JOURNAL OF OVARIAN RESEARCH (2010)
Loss of HER2 Amplification Following Trastuzumab-Based Neoadjuvant Systemic Therapy and Survival Outcomes
Elizabeth A. Mittendorf et al.
CLINICAL CANCER RESEARCH (2009)
Epitope mapping and structural analysis of an anti-ErbB2 antibody A21: Molecular basis for tumor inhibitory mechanism
Siyi Hu et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2008)
Structural basis for inhibition of the epidermal growth factor receptor by cetuximab
SQ Li et al.
CANCER CELL (2005)
Synergistic down-regulation of receptor tyrosine kinases by combinations of mAbs: Implications for cancer immunotherapy
LM Friedman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex
MC Franklin et al.
CANCER CELL (2004)
Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab
HS Cho et al.
NATURE (2003)
Share Paper
